(HealthDay News) — Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have comorbid type 2 diabetes, high body mass index, and a ...

Risk increased in the 6 months after infection; elevated risk also seen in subpopulation with overweight, obesity and hospitalized patients ...

The presence or absence of left ventricular hypertrophy may predict the effect of finerenone on heart failure hospitalization risk in patients with CKD and type 2 diabetes.

Performance measures extracted from GPS and user data differentiated between those with subjective cognitive decline, cognitively healthy adults ...